HTG Molecular Diagnostics (STU:65H) Gross-Profit-to-Asset % : -3.24% (As of Mar. 2023)

View and export this data going back to 2017. Start your Free Trial

What is HTG Molecular Diagnostics Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. HTG Molecular Diagnostics's annualized Gross Profit for the quarter that ended in Mar. 2023 was €-0.44 Mil. HTG Molecular Diagnostics's average Total Assets over the quarter that ended in Mar. 2023 was €13.47 Mil. Therefore, HTG Molecular Diagnostics's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2023 was -3.24%.

HTG Molecular Diagnostics Gross-Profit-to-Asset % Historical Data

The historical data trend for HTG Molecular Diagnostics's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HTG Molecular Diagnostics Gross-Profit-to-Asset % Chart

HTG Molecular Diagnostics Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

51.13

23.43

10.77

15.24

7.75

HTG Molecular Diagnostics Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															4.53	7.70	13.49	10.09	-3.24

Competitive Comparison of HTG Molecular Diagnostics's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, HTG Molecular Diagnostics's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HTG Molecular Diagnostics's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, HTG Molecular Diagnostics's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where HTG Molecular Diagnostics's Gross-Profit-to-Asset % falls into.

HTG Molecular Diagnostics Gross-Profit-to-Asset % Calculation

HTG Molecular Diagnostics's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2022 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2022 )	/	( (Total Assets (A: Dec. 2021 )	+	Total Assets (A: Dec. 2022 ))	/ count )
	=	1.694	/	( (26.958	+	16.782)	/ 2 )
	=	1.694	/	21.87
	=	7.75 %

HTG Molecular Diagnostics's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Mar. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Mar. 2023 ))	/ count )
	=	-0.436	/	( (16.782	+	10.149)	/ 2 )
	=	-0.436	/	13.4655
	=	-3.24 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

HTG Molecular Diagnostics Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of HTG Molecular Diagnostics's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

HTG Molecular Diagnostics (STU:65H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » HTG Molecular Diagnostics Inc (STU:65H) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

HTGMQ:USA

Address

3430 E. Global Loop, Tucson, AZ, USA, 85706

Website

https://www.htgmolecular.com

HTG Molecular Diagnostics Inc is a commercial-stage RNA platform-based life sciences company focused on advancing the promise of precision medicine. Its proprietary NGS-adapted chemistry and HTG EdgeSeq platform automates sample processing and can quickly, robustly, and simultaneously profile hundreds or thousands of molecular targets using a relatively small amount of biological samples, in liquid or solid forms. Its products include instruments, consumables, and software that combine to form its HTG EdgeSeq platform. The company's menu of HTG EdgeSeq molecular profiling panels is automated on its HTG EdgeSeq platform, applying genomic sequencing tools to quickly generate gene expression data using its simplified workflow for customers.

HTG Molecular Diagnostics (STU:65H) Headlines

No Headlines